China Biosimilar Drug Market Report & Forecast 2021-2027

China Biosimilar Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Biosimilar Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Biosimilar Drug Overall Market Size
2.1 China Biosimilar Drug Market Size: 2021 VS 2027
2.2 China Biosimilar Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 China Biosimilar Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Biosimilar Drug Players in China Market
3.2 Top China Biosimilar Drug Companies Ranked by Revenue
3.3 China Biosimilar Drug Revenue by Companies
3.4 China Biosimilar Drug Sales by Companies
3.5 China Biosimilar Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biosimilar Drug Companies in China Market, by Revenue in 2020
3.7 Manufacturers Biosimilar Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Drug Players in China Market
3.8.1 List of Tier 1 Biosimilar Drug Companies in China
3.8.2 List of Tier 2 and Tier 3 Biosimilar Drug Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Biosimilar Drug Market Size Markets, 2021 & 2027
4.1.2 Injection
4.1.3 Tablets
4.1.4 Other Types
4.2 By Type - China Biosimilar Drug Revenue & Forecasts
4.2.1 By Type - China Biosimilar Drug Revenue, 2016-2021
4.2.2 By Type - China Biosimilar Drug Revenue, 2022-2027
4.2.3 By Type - China Biosimilar Drug Revenue Market Share, 2016-2027
4.3 By Type - China Biosimilar Drug Sales & Forecasts
4.3.1 By Type - China Biosimilar Drug Sales, 2016-2021
4.3.2 By Type - China Biosimilar Drug Sales, 2022-2027
4.3.3 By Type - China Biosimilar Drug Sales Market Share, 2016-2027
4.4 By Type - China Biosimilar Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Biosimilar Drug Market Size, 2021 & 2027
5.1.2 Ankylosing Spondylitis
5.1.3 Tumor
5.1.4 Rheumatoid Arthrtis
5.1.5 Cardiovascular
5.1.6 Other Application
5.2 By Application - China Biosimilar Drug Revenue & Forecasts
5.2.1 By Application - China Biosimilar Drug Revenue, 2016-2021
5.2.2 By Application - China Biosimilar Drug Revenue, 2022-2027
5.2.3 By Application - China Biosimilar Drug Revenue Market Share, 2016-2027
5.3 By Application - China Biosimilar Drug Sales & Forecasts
5.3.1 By Application - China Biosimilar Drug Sales, 2016-2021
5.3.2 By Application - China Biosimilar Drug Sales, 2022-2027
5.3.3 By Application - China Biosimilar Drug Sales Market Share, 2016-2027
5.4 By Application - China Biosimilar Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CP Guojian Pharma
6.1.1 CP Guojian Pharma Corporation Information
6.1.2 CP Guojian Pharma Overview
6.1.3 CP Guojian Pharma Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.1.4 CP Guojian Pharma Biosimilar Drug Product Description
6.1.5 CP Guojian Pharma Recent Developments
6.2 Biotech Pharma
6.2.1 Biotech Pharma Corporation Information
6.2.2 Biotech Pharma Overview
6.2.3 Biotech Pharma Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.2.4 Biotech Pharma Biosimilar Drug Product Description
6.2.5 Biotech Pharma Recent Developments
6.3 Celgen Pharma
6.3.1 Celgen Pharma Corporation Information
6.3.2 Celgen Pharma Overview
6.3.3 Celgen Pharma Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.3.4 Celgen Pharma Biosimilar Drug Product Description
6.3.5 Celgen Pharma Recent Developments
6.4 Henlius
6.4.1 Henlius Corporation Information
6.4.2 Henlius Overview
6.4.3 Henlius Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.4.4 Henlius Biosimilar Drug Product Description
6.4.5 Henlius Recent Developments
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Overview
6.5.3 Amgen Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.5.4 Amgen Biosimilar Drug Product Description
6.5.5 Amgen Recent Developments
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Overview
6.6.3 Eli Lilly Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.6.4 Eli Lilly Biosimilar Drug Product Description
6.6.5 Eli Lilly Recent Developments
6.7 Sandoz
6.7.1 Sandoz Corporation Information
6.7.2 Sandoz Overview
6.7.3 Sandoz Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.7.4 Sandoz Biosimilar Drug Product Description
6.7.5 Sandoz Recent Developments
6.8 Changchun High Tech
6.8.1 Changchun High Tech Corporation Information
6.8.2 Changchun High Tech Overview
6.8.3 Changchun High Tech Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.8.4 Changchun High Tech Biosimilar Drug Product Description
6.8.5 Changchun High Tech Recent Developments
6.9 Innovent
6.9.1 Innovent Corporation Information
6.9.2 Innovent Overview
6.9.3 Innovent Biosimilar Drug Sales and Revenue in China Market (2016-2021)
6.9.4 Innovent Biosimilar Drug Product Description
6.9.5 Innovent Recent Developments
7 China Biosimilar Drug Production Capacity, Analysis
7.1 China Biosimilar Drug Production Capacity, 2016-2027
7.2 Biosimilar Drug Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Biosimilar Drug Supply Chain Analysis
9.1 Biosimilar Drug Industry Value Chain
9.2 Biosimilar Drug Upstream Market
9.3 Biosimilar Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Biosimilar Drug Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Biosimilar Drug in China Market
Table 2. Top Biosimilar Drug Players in China Market, Ranking by Revenue (2019)
Table 3. China Biosimilar Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Biosimilar Drug Revenue Share by Companies, 2016-2021
Table 5. China Biosimilar Drug Sales by Companies, (K Dose), 2016-2021
Table 6. China Biosimilar Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Biosimilar Drug Price (2016-2021) & (USD/Dose)
Table 8. Manufacturers Biosimilar Drug Product Type
Table 9. List of Tier 1 Biosimilar Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Biosimilar Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Injection
Table 12. Major Manufacturers of Tablets
Table 13. By Type - China Biosimilar Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Biosimilar Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Biosimilar Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Biosimilar Drug Sales (K Dose), 2016-2021
Table 17. By Type - China Biosimilar Drug Sales (K Dose), 2022-2027
Table 18. By Application - China Biosimilar Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Biosimilar Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Biosimilar Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Biosimilar Drug Sales (K Dose), 2016-2021
Table 22. By Application - China Biosimilar Drug Sales (K Dose), 2022-2027
Table 23. CP Guojian Pharma Corporation Information
Table 24. CP Guojian Pharma Description and Major Businesses
Table 25. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 26. CP Guojian Pharma Biosimilar Drug Product
Table 27. CP Guojian Pharma Recent Developments
Table 28. Biotech Pharma Corporation Information
Table 29. Biotech Pharma Description and Major Businesses
Table 30. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 31. Biotech Pharma Biosimilar Drug Product
Table 32. Biotech Pharma Recent Developments
Table 33. Celgen Pharma Corporation Information
Table 34. Celgen Pharma Description and Major Businesses
Table 35. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 36. Celgen Pharma Biosimilar Drug Product
Table 37. Celgen Pharma Recent Developments
Table 38. Henlius Corporation Information
Table 39. Henlius Description and Major Businesses
Table 40. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 41. Henlius Biosimilar Drug Product
Table 42. Henlius Recent Developments
Table 43. Amgen Corporation Information
Table 44. Amgen Description and Major Businesses
Table 45. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 46. Amgen Biosimilar Drug Product
Table 47. Amgen Recent Developments
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Major Businesses
Table 50. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 51. Eli Lilly Biosimilar Drug Product
Table 52. Eli Lilly Recent Developments
Table 53. Sandoz Corporation Information
Table 54. Sandoz Description and Major Businesses
Table 55. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 56. Sandoz Biosimilar Drug Product
Table 57. Sandoz Recent Developments
Table 58. Changchun High Tech Corporation Information
Table 59. Changchun High Tech Description and Major Businesses
Table 60. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 61. Changchun High Tech Biosimilar Drug Product
Table 62. Changchun High Tech Recent Developments
Table 63. Innovent Corporation Information
Table 64. Innovent Description and Major Businesses
Table 65. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021)
Table 66. Innovent Biosimilar Drug Product
Table 67. Innovent Recent Developments
Table 68. Biosimilar Drug Production Capacity (K Dose) of Key Manufacturers in China Market, 2019-2021 (K Dose)
Table 69. China Biosimilar Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Biosimilar Drug Market Opportunities & Trends in China Market
Table 71. Biosimilar Drug Market Drivers in China Market
Table 72. Biosimilar Drug Market Restraints in China Market
Table 73. Biosimilar Drug Raw Materials
Table 74. Biosimilar Drug Raw Materials Suppliers in China Market
Table 75. Typical Biosimilar Drug Downstream
Table 76. Biosimilar Drug Downstream Clients in China Market
Table 77. Biosimilar Drug Distributors and Sales Agents in China Market
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Biosimilar Drug Segment by Type
Figure 3. Biosimilar Drug Segment by Application
Figure 4. China Biosimilar Drug Market Overview: 2020
Figure 5. China Biosimilar Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Biosimilar Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Biosimilar Drug Sales in China Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilar Drug Revenue in 2020
Figure 9. Injection Product Picture
Figure 10. Tablets Product Picture
Figure 11. Other Types Product Picture
Figure 12. By Type - China Biosimilar Drug Sales Market Share, 2016-2027
Figure 13. By Type - China Biosimilar Drug Revenue Market Share, 2016-2027
Figure 14. By Type - China Biosimilar Drug Price (USD/Dose), 2016-2027
Figure 15. Ankylosing Spondylitis
Figure 16. Tumor
Figure 17. Rheumatoid Arthrtis
Figure 18. Cardiovascular
Figure 19. Other Application
Figure 20. By Application - China Biosimilar Drug Sales Market Share, 2016-2027
Figure 21. By Application - China Biosimilar Drug Revenue Market Share, 2016-2027
Figure 22. By Application - China Biosimilar Drug Price (USD/Dose), 2016-2027
Figure 23. CP Guojian Pharma Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Biotech Pharma Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Celgen Pharma Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Henlius Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Amgen Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Eli Lilly Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Sandoz Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Changchun High Tech Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Innovent Biosimilar Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. China Biosimilar Drug Production Capacity (K Dose), 2016-2027
Figure 33. Biosimilar Drug Industry Value Chain
Figure 34. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs